Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Legato Merger III | LEGT | Jan 15, 2025 | 10.32 | -0.02 |
Legend Biotech ADR | LEGN | Jan 15, 2025 | 31.53 | -0.35 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Jan 15, 2025 | 38.29 | +0.47 |
Leggett & Platt | LEG | Jan 15, 2025 | 10.73 | +3.67 |
Leidos | LDOS | Jan 15, 2025 | 155.25 | +1.63 |
Leishen Energy Holding Co | LSE | Jan 15, 2025 | 7.54 | 0.00 |
LeMaitre Vascular | LMAT | Jan 15, 2025 | 97.76 | +1.99 |
Lemonade | LMND | Jan 15, 2025 | 31.83 | +1.79 |
LendingClub | LC | Jan 15, 2025 | 16.30 | +5.71 |
LendingTree | TREE | Jan 15, 2025 | 38.52 | +5.36 |
Lendway | LDWY | Jan 15, 2025 | 4.65 | -1.06 |
Lennar A | LEN | Jan 15, 2025 | 138.57 | +2.51 |
Lennar B | LEN-B | Jan 15, 2025 | 132.26 | +2.65 |
Lennox International | LII | Jan 15, 2025 | 630.76 | +0.49 |
LENSAR | LNSR | Jan 15, 2025 | 8.12 | +6.01 |
LENZ Therapeutics | LENZ | Jan 15, 2025 | 22.91 | +2.46 |
Leonardo DRS | DRS | Jan 15, 2025 | 35.08 | +1.68 |
Lesaka Technologies | LSAK | Jan 15, 2025 | 5.24 | +0.77 |
Leslies | LESL | Jan 15, 2025 | 2.22 | +0.91 |
Levi Strauss & Co A | LEVI | Jan 15, 2025 | 17.72 | +1.90 |
Lexaria Bioscience | LEXX | Jan 15, 2025 | 1.90 | -1.55 |
Lexeo Therapeutics | LXEO | Jan 15, 2025 | 5.49 | -5.34 |
Lexicon Pharmaceuticals | LXRX | Jan 15, 2025 | 0.73 | +5.16 |
LexinFintech ADR | LX | Jan 15, 2025 | 6.38 | +1.92 |
LG Display ADR | LPL | Jan 15, 2025 | 3.18 | -2.15 |
LGI Homes | LGIH | Jan 15, 2025 | 92.36 | +5.87 |
LGL Group | LGL | Jan 15, 2025 | 6.62 | +2.64 |
Li Auto ADR | LI | Jan 15, 2025 | 21.88 | -2.02 |
Li Bang International | LBGJ | Jan 15, 2025 | 2.80 | 0.00 |
Li-Cycle | LICY | Jan 15, 2025 | 1.10 | -27.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.